JS

Jnanendra Samal

Active Director Director DIN 02306699
DIN 02306699 First appointment Apr 2007 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2007
Shareholding value •••• Premium profile

About Jnanendra Samal

Data last updated:

Jnanendra Samal is a Director at Urence Pharma(India)Private Limited (since 2007). The company operates in Trading. Urence Pharma(India)Private Limited reported revenue of ₹6.3 Lakh (FY 2016).

DIN 02306699
Primary Designation Director
Industry Trading
First Appointment 30 Apr 2007
Oldest Company Age 19 yrs
Largest company Urence Pharma(India)Private Limited · ₹6.3 Lakh (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Urence Pharma(India)Private Limited U51397OR2007PTC009308
Director30 Apr 20072007₹6.3 Lakh (FY 2016)Dormant Under Section 455

Board colleagues of Jnanendra Samal

NameDINCompanyDesignation
Dharmendra Samal03486546Urence Pharma(India)Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Urence Pharma(India)Private Limited
Premium access

Shareholding and investment profile for Jnanendra Samal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jnanendra Samal

Jnanendra Samal currently holds 1 directorship: Urence Pharma(India)Private Limited (Director, since 30 Apr 2007, revenue ₹6.3 Lakh (FY 2016)).

Jnanendra Samal was first appointed on 30 Apr 2007 as Director at Urence Pharma(India)Private Limited.

The current boards of Jnanendra Samal's companies include Dharmendra Samal (Urence Pharma(India)Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available